PTC Therapeutics has acquired 3 companies, including 2 in the last 5 years.
PTC Therapeutics’ largest acquisition to date was in 2018, when it acquired Agilis Biotherapeutics for $200M. PTC Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to PTC Therapeutics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 2